470
Views
24
CrossRef citations to date
0
Altmetric
Review

Invasive Nocardiosis: Disease Presentation, Diagnosis and Treatment – Old Questions, New Answers?

, , &
Pages 4601-4613 | Published online: 22 Dec 2020

References

  • Nocard E. Note sur la maladie des boeufs de la Gouadeloupe connue sous le nom de farcin. Ann Inst Pasteur. 1888;2:293–302.
  • Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006;19(2):259–282. doi:10.1128/CMR.19.2.259-282.200616614249
  • Lebeaux D, Bergeron E, Berthet J, et al. Antibiotic susceptibility testing and species identification of Nocardia isolates: a retrospective analysis of data from a French expert laboratory, 2010–2015. Clin Microbiol Infect. 2019;25(4):489–495. doi:10.1016/j.cmi.2018.06.01329933049
  • Minero MV, Marin M, Cercenado E, Rabadan PM, Bouza E, Munoz P. Nocardiosis at the turn of the century. Medicine (Baltimore). 2009;88(4):250–261. doi:10.1097/MD.0b013e3181afa1c819593231
  • Tremblay J, Thibert L, Alarie I, Valiquette L, Pepin J. Nocardiosis in Quebec, Canada, 1988–2008. Clin Microbiol Infect. 2011;17(5):690–696. doi:10.1111/j.1469-0691.2010.03306.x20636427
  • Welsh O, Vera-Cabrera L, Welsh E, Salinas MC. Actinomycetoma and advances in its treatment. Clin Dermatol. 2012;30(4):372–381. doi:10.1016/j.clindermatol.2011.06.02722682184
  • Coussement J, Lebeaux D, Rouzaud C, Lortholary O. Nocardia infections in solid organ and hematopoietic stem cell transplant recipients. Curr Opin Infect Dis. 2017;30(6):545–551. doi:10.1097/QCO.000000000000040428922286
  • Margalit I, Muhsen K, Ben Ari Y, et al. Nocardia colonization in contrast to nocardiosis: a comparison of patients’ clinical characteristics. Eur J Clin Microbiol Infect Dis. 2020;39(4):759–763. doi:10.1007/s10096-019-03796-531863237
  • Beaman BL, Beaman L. Nocardia species: host-parasite relationships. Clin Microbiol Rev. 1994;7(2):213–264. doi:10.1128/CMR.7.2.2138055469
  • Fujita T, Ikari J, Watanabe A, Tatsumi K. Clinical characteristics of pulmonary nocardiosis in immunocompetent patients. J Infect Chemother. 2016;22(11):738–743. doi:10.1016/j.jiac.2016.08.00427615155
  • Rodriguez-Nava V, Durupt S, Chyderiotis S, et al. A French multicentric study and review of pulmonary Nocardia spp. in cystic fibrosis patients. Med Microbiol Immunol. 2015;204(4):493–504. doi:10.1007/s00430-014-0360-325344657
  • Woodworth MH, Saullo JL, Lantos PM, Cox GM, Stout JE. Increasing Nocardia incidence associated with bronchiectasis at a tertiary care center. Ann Am Thorac Soc. 2017;14(3):347–354. doi:10.1513/AnnalsATS.201611-907OC28231023
  • Haussaire D, Fournier PE, Djiguiba K, et al. Nocardiosis in the south of France over a 10-years period, 2004–2014. Int J Infect Dis. 2017;57:13–20. doi:10.1016/j.ijid.2017.01.00528088585
  • Coussement J, Lebeaux D, van Delden C, et al. Nocardia infection in solid organ transplant recipients: a multicenter European case-control study. Clin Infect Dis. 2016;63(3):338–345. doi:10.1093/cid/ciw24127090987
  • Peleg AY, Husain S, Qureshi ZA, et al. Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis. 2007;44(10):1307–1314. doi:10.1086/51434017443467
  • Wang HL, Seo YH, LaSala PR, Tarrand JJ, Han XY. Nocardiosis in 132 patients with cancer: microbiological and clinical analyses. Am J Clin Pathol. 2014;142(4):513–523. doi:10.1309/AJCPW84AFTUWMHYU25239419
  • Lafont E, Marciano BE, Mahlaoui N, et al. Nocardiosis associated with primary immunodeficiencies (Nocar-DIP): an international retrospective study and literature review. J Clin Immunol. 2020;40(8):1144–1155. doi:10.1007/s10875-020-00866-832920680
  • Rosen LB, Rocha Pereira N, Figueiredo C, et al. Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated/extrapulmonary nocardiosis. Clin Infect Dis. 2015;60(7):1017–1025. doi:10.1093/cid/ciu96825472947
  • Blackmon KN, Ravenel JG, Gomez JM, Ciolino J, Wray DW. Pulmonary nocardiosis: computed tomography features at diagnosis. J Thorac Imaging. 2011;26(3):224–229. doi:10.1097/RTI.0b013e3181f45dd521785288
  • Anagnostou T, Arvanitis M, Kourkoumpetis TK, Desalermos A, Carneiro HA, Mylonakis E. Nocardiosis of the central nervous system: experience from a general hospital and review of 84 cases from the literature. Medicine (Baltimore). 2014;93(1):19–32. doi:10.1097/MD.000000000000001224378740
  • Chaussade H, Lebeaux D, Gras G, et al. Nocardia arthritis: 3 cases and literature review. Medicine (Baltimore). 2015;94(42):e1671. doi:10.1097/MD.000000000000167126496274
  • Playe M, Einfalt M, Toch SR, Froissart A, Bodardel G. 18F-FDG imaging of a case of disseminated nocardiosis. Clin Nucl Med. 2020;45(1):55–56. doi:10.1097/RLU.000000000000284231789913
  • Gajdács M, Urbán E. The relevance of anaerobic bacteria in brain abscesses: a ten-year retrospective analysis (2008–2017). Infect Dis. 2019;51(10):779–781. doi:10.1080/23744235.2019.1648857
  • Saubolle MA, Sussland D. Nocardiosis: review of clinical and laboratory experience. J Clin Microbiol. 2003;41(10):4497–4501. doi:10.1128/JCM.41.10.4497-4501.200314532173
  • Gajdács M, Urbán E, Terhes G. Microbiological and clinical aspects of cervicofacial actinomyces infections: an overview. Dent J. 2019;7(3):85. doi:10.3390/dj7030085
  • Rodriguez-Nava V, Lebeaux D, Lortholary O, Boiron P. Nocardia et nocardioses. Précis de Bactériologie Clinique. 3rd ed. ESKA/LACASSAGNE; 2018:809–827.
  • Couble A, Rodriguez-Nava V, de Montclos MP, Boiron P, Laurent F. Direct detection of Nocardia spp. in clinical samples by a rapid molecular method. J Clin Microbiol. 2005;43(4):1921–1924. doi:10.1128/JCM.43.4.1921-1924.200515815019
  • Brown JM, Pham KN, McNeil MM, Lasker BA. Rapid identification of Nocardia farcinica clinical isolates by a PCR assay targeting a 314-base-pair species-specific DNA fragment. J Clin Microbiol. 2004;42(8):3655–3660. doi:10.1128/JCM.42.8.3655-3660.200415297512
  • Rouzaud C, Rodriguez-Nava V, Catherinot E, et al. Clinical assessment of a Nocardia PCR-based assay for diagnosis of nocardiosis. J Clin Microbiol. 2018;56(6). doi:10.1128/JCM.00002-18
  • Coussement J, Lebeaux D, El Bizri N, et al. Nocardia polymerase chain reaction (PCR)-based assay performed on bronchoalveolar lavage fluid after lung transplantation: a prospective pilot study. PLoS One. 2019;14(2):e0211989. doi:10.1371/journal.pone.021198930802260
  • Conville PS, Brown-Elliott BA, Smith T, Zelazny AM. The complexities of Nocardia taxonomy and identification. J Clin Microbiol. 2018;56(1).
  • Conville PS, Zelazny AM, Witebsky FG. Analysis of secA1 gene sequences for identification of Nocardia species. J Clin Microbiol. 2006;44(8):2760–2766. doi:10.1128/JCM.00155-0616891489
  • Rodriguez-Nava V, Couble A, Devulder G, Flandrois JP, Boiron P, Laurent F. Use of PCR-restriction enzyme pattern analysis and sequencing database for hsp65 gene-based identification of Nocardia species. J Clin Microbiol. 2006;44(2):536–546. doi:10.1128/JCM.44.2.536-546.200616455910
  • Sánchez-Herrera K, Sandoval H, Mouniee D, et al. Molecular identification of Nocardia species using the sodA gene: identificación molecular de especies de Nocardia utilizando el gen sodA. New Microbes New Infect. 2017;19:96–116. doi:10.1016/j.nmni.2017.03.00828794885
  • Kong F, Wang H, Zhang E, et al. secA1 gene sequence polymorphisms for species identification of Nocardia species and recognition of intraspecies genetic diversity. J Clin Microbiol. 2010;48(11):3928–3934. doi:10.1128/JCM.01113-1020810768
  • McTaggart LR, Richardson SE, Witkowska M, Zhang SX. Phylogeny and identification of Nocardia species on the basis of multilocus sequence analysis. J Clin Microbiol. 2010;48(12):4525–4533. doi:10.1128/JCM.00883-1020844218
  • Tamura T, Ohji S, Ichikawa N, et al. Reclassification of Nocardia species based on whole genome sequence and associated phenotypic data. J Antibiot (Tokyo). 2018;71(7):633–641. doi:10.1038/s41429-018-0043-129618770
  • Vautrin F, Bergeron E, Dubost A, et al. Genome sequences of three Nocardia cyriacigeorgica strains and one nocardia asteroides strain. Microbiol Resour Announc. 2019;8(33). doi:10.1128/MRA.00600-19
  • Euzeby JP. List of bacterial names with standing in nomenclature: a folder available on the internet. Int J Syst Evol Microbiol. 1997;47(2):590–592. doi:10.1099/00207713-47-2-590
  • Blosser SJ, Drake SK, Andrasko JL, et al. Multicenter matrix-assisted laser desorption ionization-time of flight mass spectrometry study for identification of clinically relevant Nocardia spp. J Clin Microbiol. 2016;54(5):1251–1258. doi:10.1128/JCM.02942-1526912758
  • Body BA, Beard MA, Slechta ES, et al. Evaluation of the Vitek MS v3.0 matrix-assisted laser desorption Ionization–time of flight mass spectrometry system for identification of mycobacterium and Nocardia species. J Clin Microbiol. 2018;56(6):e00237–18. doi:10.1128/JCM.00237-1829643203
  • Girard V, Mailler S, Polsinelli S, et al. Routine identification of Nocardia species by MALDI-TOF mass spectrometry. Diagn Microbiol Infect Dis. 2017;87(1):7–10. doi:10.1016/j.diagmicrobio.2016.09.02427802877
  • Durand T, Vautrin F, Bergeron E, et al. Assessment of VITEK® MS IVD database V3.0 for identification of Nocardia spp. using two culture media and comparing direct smear and protein extraction procedures. Eur J Clin Microbiol Infect Dis. 2020;39(3):559–567. doi:10.1007/s10096-019-03758-x31758438
  • McTaggart LR, Chen Y, Poopalarajah R, Kus JV. Incubation time and culture media impact success of identification of Nocardia spp. by MALDI-ToF mass spectrometry. Diagn Microbiol Infect Dis. 2018;92(4):270–274. doi:10.1016/j.diagmicrobio.2018.06.01630025971
  • McTaggart LR, Doucet J, Witkowska M, Richardson SE. Antimicrobial susceptibility among clinical Nocardia species identified by multilocus sequence analysis. Antimicrob Agents Chemother. 2015;59(1):269–275. doi:10.1128/AAC.02770-1425348540
  • CLSI. Performance Standards for Susceptibility Testing of Mycobacteria, Nocardia Spp. and Other Aerobic Actinomycetes. 1st ed. CSLSI supplement M62 Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
  • Conville PS, Brown-Elliott BA, Wallace RJ, et al. Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species. J Clin Microbiol. 2012;50(4):1270–1280. doi:10.1128/JCM.00994-1122219309
  • Valdezate S, Garrido N, Carrasco G, et al. Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain. J Antimicrob Chemother. 2017;72(3):754–761.27999029
  • Schlaberg R, Fisher MA, Hanson KE. Susceptibility profiles of Nocardia isolates based on current taxonomy. Antimicrob Agents Chemother. 2014;58(2):795–800. doi:10.1128/AAC.01531-1324247124
  • Gombert ME, Aulicino TM. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides. Antimicrob Agents Chemother. 1983;24(5):810–811. doi:10.1128/AAC.24.5.8106362558
  • Gombert ME, Aulicino TM, duBouchet L, Silverman GE, Sheinbaum WM. Therapy of experimental cerebral nocardiosis with imipenem, amikacin, trimethoprim-sulfamethoxazole, and minocycline. Antimicrob Agents Chemother. 1986;30(2):270–273. doi:10.1128/AAC.30.2.2703532945
  • Gombert ME, Berkowitz LB, Aulicino TM, duBouchet L. Therapy of pulmonary nocardiosis in immunocompromised mice. Antimicrob Agents Chemother. 1990;34(9):1766–1768.2285288
  • Lebeaux D, Freund R, van Delden C, et al. Outcome and treatment of nocardiosis after solid organ transplantation: new insights from a European study. Clin Infect Dis. 2017;64(10):1396–1405. doi:10.1093/cid/cix12428329348
  • Nau R, Sörgel F, Eiffert H. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev. 2010;23(4):858–883. doi:10.1128/CMR.00007-1020930076
  • Brown-Elliott BA, Biehle J, Conville PS, et al. Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey. J Clin Microbiol. 2012;50(3):670–672. doi:10.1128/JCM.06243-1122170936
  • Ercibengoa M, Càmara J, Tubau F, et al. A multicentre analysis of Nocardia pneumonia in Spain: 2010–2016. Int J Infect Dis. 2020;90:161–166. doi:10.1016/j.ijid.2019.10.03231693939
  • Conan PL, Matignon M, Bleibtreu A, et al. Traitement par monothérapie de cotrimoxazole des nocardioses chez les patients transplantés d’organe solide: résultats d’une étude européenne multicentrique rétrospective. Med Mal Infect. 2019;49(4):S76. doi:10.1016/j.medmal.2019.04.182
  • Davidson N, Grigg MJ, McGuinness SL, Baird RJ, Anstey NM. Safety and outcomes of linezolid use for nocardiosis. Open Forum Infect Dis. 2020;7(4):ofaa090. doi:10.1093/ofid/ofaa09032258209
  • Shen T, Wu L, Geng L, Wei Z, Zheng S. Successful treatment of pulmonary Nocardia farcinica infection with linezolid: case report and literature review. Braz J Infect Dis. 2011;15(5):486–489.22230859
  • Tripodi MF, Durante-Mangoni E, Fortunato R, et al. In vitro activity of multiple antibiotic combinations against Nocardia: relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis. Transpl Infect Dis. 2011;13(4):335–343. doi:10.1111/j.1399-3062.2010.00588.x21156012
  • MacGowan AP. Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections. J Antimicrob Chemother. 2003;51(Suppl 2):ii17–25. doi:10.1093/jac/dkg24812730139
  • Restrepo A, Clark NM. Nocardia infections in solid organ transplantation: guidelines from the infectious diseases community of practice of the American society of transplantation. Clin Transplant. 2019;33(9):e13509. doi:10.1111/ctr.1350930817024
  • Wallace RJ, Septimus EJ, Williams TW, et al. Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis. 1982;4(2):315–325. doi:10.1093/clinids/4.2.3156981158
  • Mootsikapun P, Intarapoka B, Liawnoraset W. Nocardiosis in Srinagarind Hospital, Thailand: review of 70 cases from 1996–2001. Int J Infect Dis. 2005;9(3):154–158. doi:10.1016/j.ijid.2004.06.01115840456
  • Soman R, Koparkar V, Almeida A, Shetty A, Rodrigues C. Paradoxical response in cerebral nocardiosis in a renal transplant recipient. J Assoc Physicians India. 2018;66(9):91–92.
  • Douglas AP, Thursky KA, Worth LJ, et al. FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging. Eur J Nucl Med Mol Imaging. 2019;46(1):166–173. doi:10.1007/s00259-018-4062-829882160
  • Brown-Elliott BA, Killingley J, Vasireddy S, Bridge L, Wallace RJ. In vitro comparison of ertapenem, meropenem, and imipenem against isolates of rapidly growing mycobacteria and Nocardia by use of broth microdilution and etest. J Clin Microbiol. 2016;54(6):1586–1592. doi:10.1128/JCM.00298-1627053677
  • Gomez-Flores A, Welsh O, Said-Fernandez S, Lozano-Garza G, Tavarez-Alejandro RE, Vera-Cabrera L. In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis. Antimicrob Agents Chemother. 2004;48(3):832–837. doi:10.1128/AAC.48.3.832-837.200414982772
  • Hamdi AM, Fida M, Deml SM, Abu Saleh OM, Wengenack NL. Retrospective analysis of antimicrobial susceptibility profiles of Nocardia species from a tertiary hospital and reference laboratory, 2011 to 2017. Antimicrob Agents Chemother. 2020;64(3).
  • Rouzaud C, Mainardi JL, Lortholary O, Lebeaux D. Traitement des nocardioses: plus de questions que de réponses? Jl des Anti-infectieux. 2014;16:175–184. doi:10.1016/j.antinf.2014.10.001